How to Identify a Tumor by Feel, Scan, or Blood Test

Tumors are identified through a combination of physical signs you can detect yourself, imaging scans that reveal growths inside the body, and biopsies that confirm whether a growth is cancerous. No single method works alone. The process typically starts with noticing something unusual, either a physical change or a persistent symptom, and then moves through increasingly precise medical tools until a definitive answer is reached.

What a Tumor Feels Like

Tumors you can detect by touch usually feel like a new bump or lump that wasn’t there before. Cancerous tumors tend to feel firm and relatively fixed in place, while benign lumps and cysts are more likely to feel soft and movable under the skin. That said, these are tendencies, not rules. A firm, immovable lump isn’t automatically cancer, and a soft, movable one isn’t automatically safe. What matters most is that it’s new or changing.

The location of the lump matters too. Growths in the breast, testicles, neck, armpits, and groin are easier to feel because they sit close to the surface. Tumors deeper in the body, in organs like the liver, lungs, or pancreas, rarely produce a palpable mass and are almost always found through imaging or when they start causing symptoms.

The ABCDE Rule for Skin Tumors

Skin tumors, particularly melanoma, have their own visual identification system. The National Cancer Institute uses five features to describe early warning signs:

  • Asymmetry: One half of the mole or spot doesn’t match the other half.
  • Border: The edges are ragged, notched, or blurred, and pigment may spread into surrounding skin.
  • Color: The spot contains multiple shades of brown, black, or tan, possibly with areas of white, gray, red, pink, or blue.
  • Diameter: Most melanomas are larger than 6 millimeters (about the width of a pencil eraser), though they can be smaller.
  • Evolving: The mole has visibly changed in size, shape, or color over the past few weeks or months.

A mole that checks even one or two of these boxes is worth having examined. You don’t need all five features present for a growth to be concerning.

Symptoms That Can Signal a Hidden Tumor

Many tumors don’t produce a visible or touchable lump. Instead, they announce themselves through systemic changes that are easy to dismiss individually but become significant when they persist. The most common red flags include unexplained weight loss, persistent fatigue, poor appetite, and pain that doesn’t have an obvious cause, particularly in the back, chest, abdomen, or bones of the legs and hips. Shortness of breath and anemia (low red blood cell counts, which can cause pale skin and exhaustion) are also associated with hidden cancers.

The key word in all of this is “persistent.” A cough that lasts a week during cold season is ordinary. Unexplained chest or shoulder pain lasting longer than three weeks warrants investigation for possible lung involvement. Rectal bleeding combined with looser or more frequent stools persisting six weeks or more in someone over 40 is a recognized red flag for lower gastrointestinal cancer. A general clinical guideline is that red flag symptoms present for three or more weeks, especially if they aren’t improving, should prompt an urgent evaluation.

Benign vs. Malignant Tumors

Not every tumor is cancer. Benign tumors grow in place and do not invade surrounding tissues or spread to other parts of the body. They can still cause problems if they press on nerves or organs, but the cells themselves stay contained. Malignant tumors are the opposite: their cells break through the boundaries of normal tissue and can spread to distant sites through the bloodstream, the lymphatic system, or by seeding into body cavities. This spreading process, called metastasis, is what makes cancer dangerous.

There’s also a middle category. In situ tumors contain abnormal cells that haven’t yet broken through the membrane separating them from deeper tissue. They’re essentially pre-invasive, and catching a tumor at this stage often means it can be removed before it becomes a threat. The only reliable way to distinguish between these categories is a biopsy, where cells from the growth are examined under a microscope.

How Imaging Scans Detect Tumors

When a tumor can’t be seen or felt, imaging is usually the first tool doctors use to locate it. Each type of scan has specific strengths.

CT scans create three-dimensional cross-sections of the body, similar to looking at slices of bread. They can show whether a tumor is present and roughly how deep it sits. CT is particularly useful for scanning the chest, abdomen, and pelvis.

MRI also produces three-dimensional images but is sometimes more sensitive than CT at distinguishing between different types of soft tissue. This makes it especially valuable for evaluating the brain, spinal cord, and certain joint or organ tissues.

Ultrasound uses sound waves and works well for imaging specific body parts, such as the thyroid, breast, or liver. It can also guide doctors during biopsies. However, it’s less effective for the brain, lungs, or surveying a large area like the entire abdomen, because very small or deep masses can be difficult to detect with sound waves alone.

PET scans work differently from the others. Instead of just showing anatomy, they highlight areas of high metabolic activity, which is a hallmark of aggressive cancer cells. PET scans are most accurate for larger and more aggressive tumors, and they struggle with growths smaller than about 8 millimeters (roughly the size of a pinky fingernail). Their unique advantage is that they can sometimes detect cancer when other imaging techniques show normal results.

Blood Tests and Tumor Markers

Certain blood tests measure substances that tumors release into the bloodstream. These are called tumor markers, and while they can’t diagnose cancer on their own, they play a supporting role. PSA levels in the blood help evaluate prostate cancer risk. CA-125 is used in the diagnosis and monitoring of ovarian cancer. CEA is most commonly tracked in colorectal cancer to assess treatment response and watch for recurrence.

The limitation of tumor markers is that they can be elevated for non-cancerous reasons too. An elevated PSA, for example, can result from an enlarged prostate that has nothing to do with cancer. These tests are most useful when combined with imaging and physical findings, or when monitoring someone who has already been treated for cancer.

A newer approach called liquid biopsy analyzes fragments of tumor DNA circulating in the blood. This technology can provide information about tumors too small to appear on scans, and after cancer treatment, it can detect signs of recurrence months or even years before new tumors would be visible on imaging. Liquid biopsies are already in clinical use at major cancer centers.

How Biopsies Confirm the Diagnosis

Imaging and blood tests can raise suspicion, but a biopsy is typically the only way to confirm whether a tumor is cancerous. There are three main approaches, and which one is used depends on the tumor’s location and size.

Fine-needle aspiration uses a thin needle and syringe to draw out fluid and cells from a suspicious area. It’s the least invasive option and often used for lumps in the thyroid or lymph nodes. Core needle biopsy uses a larger needle with a cutting tip to extract a small column of tissue, providing more material for analysis than fine-needle aspiration. Both of these can often be done in an outpatient setting with local numbing.

Surgical biopsy involves making an incision to access the suspicious area directly. A surgeon may remove part of the growth or all of it. This approach is reserved for cases where needle biopsies can’t reach the tumor or when earlier biopsy results were inconclusive.

Routine Screening for People Without Symptoms

Some tumors can be caught before they cause any symptoms at all through routine screening. The U.S. Preventive Services Task Force recommends mammograms every two years for women aged 40 to 74 to screen for breast cancer. Colonoscopies are generally recommended starting at age 45 for colorectal cancer, and low-dose CT scans are used to screen for lung cancer in people with significant smoking histories.

These screenings exist because certain cancers grow silently for years before producing noticeable symptoms. By the time a tumor causes pain, weight loss, or a palpable lump, it may already be advanced. Screening catches tumors at earlier, more treatable stages, which is why sticking to recommended schedules matters even when you feel perfectly healthy.